Canadian COVID-19 Genomics Network

The Canadian COVID-19 Genomics Network, or CanCOGeN, is a country-wide, cross-agency network for large-scale SARS-CoV-2 and human host sequencing to track viral origin, spread and evolution, characterize the role of human genetics in COVID-19 disease.1)

CanCOGeN is a “consortium of Canadian federal, provincial and regional public health authorities and their healthcare partners, academia, industry, hospitals, research institutes and large-scale sequencing centres”, launched by Genome Canada in April 2020.

Affiliations

Partners

The official membership of the CanCOGeN network is composed of Genome Canada and its subsidiaries, hospital labs, partner organizations, public health labs, and university labs.2)

Genome Canada network

Hospital Labs

Partner Organizations

Provincial Public Health Labs

University Labs

1)
CanCOGeN. Genome Canada. Retrieved February 9, 2022, from https://archive.ph/LpFH3
2)
CanCOGeN Partners. Genome Canada. Retrieved February 9, 2022, from https://archive.ph/KcLqD
Back to top